BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3391343)

  • 1. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients.
    Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F
    Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
    Ciabattoni G; Cinotti GA; Pierucci A; Simonetti BM; Manzi M; Pugliese F; Barsotti P; Pecci G; Taggi F; Patrono C
    N Engl J Med; 1984 Feb; 310(5):279-83. PubMed ID: 6361565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis.
    Eriksson LO; Sturfelt G; Thysell H; Wollheim FA
    Am J Med; 1990 Sep; 89(3):313-21. PubMed ID: 2203262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients.
    Esmatjes E; Conget JI; Gaya J; Fernandez MR; Ferrer JP; Rivera F; Vilardell E
    Diabetes Care; 1990 Nov; 13(11):1114-7. PubMed ID: 2261825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
    Ylikorkala O; Pekonen F; Viinikka L
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of prostacyclin synthesis by physical exercise in type I diabetes.
    Koivisto VA; Jantunen M; Sane T; Helve E; Pelkonen R; Viinikka L; Ylikorkala O
    Diabetes Care; 1989 Oct; 12(9):609-14. PubMed ID: 2507264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitus.
    Viberti GC; Benigni A; Bognetti E; Remuzzi G; Wiseman MJ
    Diabet Med; 1989 Apr; 6(3):219-23. PubMed ID: 2523782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
    Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J
    J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sulindac on renal and extrarenal eicosanoid synthesis.
    Cibattoni G; Boss AH; Patrignani P; Catella F; Simonetti BM; Pierucci A; Pugliese F; Filabozzi P; Patrono C
    Clin Pharmacol Ther; 1987 Apr; 41(4):380-3. PubMed ID: 3549118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulindac on renal function and prostaglandin synthesis in patients with moderate chronic renal insufficiency.
    Mistry CD; Lote CJ; Currie WJ; Vandenburg M; Mallick NP
    Clin Sci (Lond); 1986 May; 70(5):501-5. PubMed ID: 3516534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites.
    Quintero E; Ginés P; Arroyo V; Rimola A; Camps J; Gaya J; Guevara A; Rodamilans M; Rodés J
    Nephron; 1986; 42(4):298-303. PubMed ID: 3515219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T; Ichikawa Y; Tojo T; Homma M
    Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics.
    Wong DG; Spence JD; Lamki L; Freeman D; McDonald JW
    Lancet; 1986 May; 1(8488):997-1001. PubMed ID: 2871333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patients.
    Koivisto VA; Leirisalo-Repo M; Pelkonen R; Turunen U; Rapola J; Viinikka L; Ylikorkala O
    Acta Diabetol; 1992; 29(1):1-5. PubMed ID: 1520898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.